Edwards Lifesciences Corp (EW)

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)

Market region: US

Address: One Edwards Way, Irvine, CA, 92614

Market capitalization

53.03 billion USD (53,034,564,000 USD)

Listing date

04/03/2000

Weighted shares outstanding

576,400,000

Share class shares outstanding

575,800,000

https://www.edwards.com